Again, comparing to RDNA2 where AMD were positioning the 6800XT at $649 as the sweetspot, they were likely plenty willing to cut down good dies for that pricing. Even a new "street" price of $800 for a 7900XT would still be a significant pricing increase gen-on-gen.
Proposals:
- 7800XT vs 6800XT at launch: Possibly, although that would heavily depend on the tradeoff between chiplet packaging + N5 vs a larger monolithic N7
- 7700XT vs 6700XT at launch: Absolutely not, N5+N6 with roughly equivalent die size in 2023 is more expensive than N7 in 2020, not to mention chiplet packaging costs, more GDDR6 VRAM,
- 7600XT vs 6600XT at launch: Setting aside that it is unlikely for N32 to have 3 cuts when the bigger N31 only has 2 for consumer at the moment, unless there are big problems with yields at N5 (there shouldn;t be), even a heavily binned N32 will have significantly thinner margins than N23 at similar pricing.
- 7500XT vs 6500XT: Same here, double the die space, vram...does not make for good margins, even if we're assuming a $100 increase in MSRP.
Keep in mind that R&D costs in the development period for RDNA3 (~2019-22) is way more expensive than RDNA 2 (~2016-19), on account of the massively increased personnel costs that every single U.S tech company faced during the COVID years as they outbid each other for talent. AMD's SG&A costs jumped from $995m in 2020 to $2.3B in 2022 for example, all these additional costs need to get amortized.
It's been nearly six months since RDNA3 has launched and so far we still don't have much in the way of official information, let alone products for RDNA3 GPUs other than N31, this doesn't strike me as a company that wants to get attention and marketshare. Frankly speaking, I don't think they care about mindshare and would be plenty happy taking those wafers and making datacenter GPUs/CPUs instead..